EGFR–c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells

EGFR–c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells

Breast cancer is one of the leading causes of morbidity and mortality among women. Epidermal growth factor receptor (EGFR) and proto-oncogene tyrosine-protein kinase Src (c-Src) are critical components of the signaling pathways that are associated with breast cancer. However, the regulatory mechanis...

Full description

Bibliographic Details
Main Authors:	Sung-Min Kwak, Jaesung Seo, Jin-Taek Hwang, Gi-Jun Sung, Ji-Hye Song, Ji-Hoon Jeong, Seung-Hyun Lee, Ho-Geun Yoon, Hyo-Kyoung Choi, Kyung-Chul Choi
Format:	Article
Language:	English
Published:	MDPI AG 2019-08-01
Series:	Cells
Subjects:	breast cancer c-Src EGFR HDAC3 pY-HDAC3<sup>Y328/331</sup> antibody
Online Access:	https://www.mdpi.com/2073-4409/8/8/930

Similar Items

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
by: Elizabeth A. Thomas
Published: (2014-05-01)

The role of HDAC3 in inflammation: mechanisms and therapeutic implications
by: Noah Watson, et al.
Published: (2024-07-01)

RGFP966 Suppresses Tumor Growth and Migration Through Inhibition of EGFR Expression in Hepatocellular Carcinoma Cells in vitro
by: Yu X, et al.
Published: (2020-01-01)

PHF12 regulates HDAC1 to promote tumorigenesis via EGFR/AKT signaling pathway in non-small cell lung cancer
by: Yiru Kong, et al.
Published: (2024-07-01)

Hdac1 and Hdac2 are essential for physiological maturation of a Cx3cr1 expressing subset of T-lymphocytes
by: Moumita Datta, et al.
Published: (2021-04-01)

The Role of HDACs and HDACi in Cartilage and Osteoarthritis
by: He Zhang, et al.
Published: (2020-09-01)

Human EGFR-2, EGFR and HDAC triple-inhibitor CUDC-101 enhances radiosensitivity of GBM cells
by: Cody D Schlaff, et al.
Published: (2015-01-01)

Circular RNA circPSAP functions as an efficient miR-331-3p sponge to regulate proliferation, apoptosis and bortezomib sensitivity of human multiple myeloma cells by upregulating HDAC4
by: Hongyan Ma, et al.
Published: (2022-05-01)

Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors
by: Emre F. Bülbül, et al.
Published: (2022-04-01)

HDAC3–ERα Selectively Regulates TNF-α-Induced Apoptotic Cell Death in MCF-7 Human Breast Cancer Cells via the p53 Signaling Pathway
by: Seung-Ho Park, et al.
Published: (2020-05-01)

Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome
by: Imran Jamal, et al.
Published: (2017-09-01)

Plant HDAC inhibitor chrysin arrest cell growth and induce <it>p21</it><sup><it>WAF1</it></sup> by altering chromatin of STAT response element in A375 cells
by: Pal-Bhadra Manika, et al.
Published: (2012-05-01)

Pathological Role of HDAC8: Cancer and Beyond
by: Ji Yoon Kim, et al.
Published: (2022-10-01)

HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability
by: Hong-Ying Dai, et al.
Published: (2023-01-01)

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
by: Tarek S. Ibrahim, et al.
Published: (2021-11-01)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
by: Yuxiang Fan, et al.
Published: (2021-09-01)

Microglial Expression of Hdac1 and Hdac2 is Dispensable for Experimental Autoimmune Encephalomyelitis (EAE) Progression
by: Moumita Datta, et al.
Published: (2020-10-01)

HDAC-an important target for improving tumor radiotherapy resistance
by: Rui Ling, et al.
Published: (2023-07-01)

MicroRNA-mediated epigenetic regulation of HDAC8 and HDAC6: Functional significance in cervical cancer
by: Debasmita Naik, et al.
Published: (2024-09-01)

HDAC3 restrains CD8-lineage genes to maintain a bi-potential state in CD4+CD8+ thymocytes for CD4-lineage commitment
by: Rachael Laura Philips, et al.
Published: (2019-01-01)

Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
by: G. R. Vanaja, et al.
Published: (2018-05-01)

Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation
by: Vidhi Gaur, et al.
Published: (2016-09-01)

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
by: Yi Luan, et al.
Published: (2022-04-01)

RGFP966 exerts neuroprotective effect via HDAC3/Nrf2 pathway after surgical brain injury in rats
by: Hai-Ping Gu, et al.
Published: (2023-07-01)

Gut microbiota-derived butyrate improved acute leptospirosis in hamster via promoting macrophage ROS mediated by HDAC3 inhibition
by: Xi Chen, et al.
Published: (2024-10-01)

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022-01-01)

Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
by: Leilei He, et al.
Published: (2019-02-01)

The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases
by: Robin E. Bonomi, et al.
Published: (2024-10-01)

Pyrotinib Targeted EGFR-STAT3/CD24 Loop-Mediated Cell Viability in TSC
by: Xiao Han, et al.
Published: (2022-09-01)

Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy
by: Nisha Holay, et al.
Published: (2023-09-01)

The efficacy of HDAC inhibitors in neoplasm treatment
by: Dominika Psiuk, et al.
Published: (2020-08-01)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
by: Gloria Manzotti, et al.
Published: (2019-08-01)

Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma
by: Mitsuhito Hirano, et al.
Published: (2021-03-01)

HDAC4 preserves skeletal muscle structure following long-term denervation by mediating distinct cellular responses
by: Eva Pigna, et al.
Published: (2018-02-01)

Inhibition of Histone Deacetylase 3 (HDAC3) Mediates Ischemic Preconditioning and Protects Cortical Neurons against Ischemia in Rats
by: Xiaoyu Yang, et al.
Published: (2016-11-01)

Coptis Chinensis affects the function of glioma cells through the down-regulation of phosphorylation of STAT3 by reducing HDAC3
by: Jiangan Li, et al.
Published: (2017-12-01)

Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
by: Yubin Lei, et al.
Published: (2017-11-01)

Essential roles of HDAC1 and 2 in lineage development and genome-wide DNA methylation during mouse preimplantation development
by: Panpan Zhao, et al.
Published: (2020-04-01)

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
by: Andressa S. Laino, et al.
Published: (2019-02-01)